Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
3.570
+0.390 (12.26%)
At close: Oct 8, 2025, 4:00 PM EDT
3.570
0.00 (0.00%)
After-hours: Oct 8, 2025, 8:00 PM EDT
Stereotaxis Market Cap
Stereotaxis has a market cap or net worth of $325.13 million as of October 8, 2025. Its market cap has increased by 82.04% in one year.
Market Cap
325.13M
Enterprise Value
323.89M
1-Year Change
82.04%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since August 12, 2004, Stereotaxis's market cap has increased from $183.10M to $325.13M, an increase of 77.57%. That is a compound annual growth rate of 2.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 7, 2025 | 288.30M | 49.22% |
Dec 31, 2024 | 193.20M | 36.54% |
Dec 29, 2023 | 141.50M | -8.65% |
Dec 30, 2022 | 154.90M | -66.50% |
Dec 31, 2021 | 462.40M | 23.27% |
Dec 31, 2020 | 375.10M | 6.26% |
Dec 31, 2019 | 353.00M | 474.92% |
Dec 31, 2018 | 61.40M | 237.36% |
Dec 29, 2017 | 18.20M | 28.17% |
Dec 30, 2016 | 14.20M | -10.69% |
Dec 31, 2015 | 15.90M | -47.52% |
Dec 31, 2014 | 30.30M | -47.49% |
Dec 31, 2013 | 57.70M | 215.30% |
Dec 31, 2012 | 18.30M | -55.90% |
Dec 30, 2011 | 41.50M | -76.45% |
Dec 31, 2010 | 176.20M | -2.22% |
Dec 31, 2009 | 180.20M | 19.97% |
Dec 31, 2008 | 150.20M | -63.64% |
Dec 31, 2007 | 413.10M | 27.11% |
Dec 29, 2006 | 325.00M | 49.56% |
Dec 30, 2005 | 217.30M | 991.96% |
Dec 31, 2004 | 19.90M | -89.13% |
Aug 12, 2004 | 183.10M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 758.63B |
Johnson & Johnson | 453.15B |
AbbVie | 406.64B |
UnitedHealth Group | 324.93B |
Novo Nordisk | 269.41B |
AstraZeneca | 265.89B |
Novartis AG | 257.47B |
Abbott Laboratories | 232.77B |